StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
218150.KQ$2150.00-3.80%
Fair $2150.00+0.0%

218150.KQ

Milae Bioresources Co., Ltd.

Consumer Defensive / Farm ProductsKOSDAQ

$2150.00

-85.00 (-3.80%)

Fairly Valued+0.0%Fair Value $2150.00Fund rank 31/100 · Data gapFallback financials|
SA 21/D
F-Score: 5/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 23%

FCF escenarios

weak_data · normalized FCF $2.6B · quality 55.3/100

Data gap 31/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 33/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

21/100

D

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -8.1%, below the 5% threshold
Thesis & Journal · 218150.KQLocal privado en este navegador · Milae Bioresources Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$41.9B

P/E

N/A

•

EV/EBITDA

488.0x

↑

ROE

-8.1%

↓

Gross Margin

15.0%

↓

Debt/Equity

0.24

↓
52-Week Range$2150
$2060$4440

TradingView lightweight chart

218150.KQ price, volumen y niveles de valoración

Último $2,150Periodo +5.9%
Fair value: $2,150

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-3.7%

FCF CAGR

+77.6%

FCF margin

5.8%

FCF / Net income

-1.21x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $67.55B · net income $-3.26B · FCF $3.95B

2022-FY → 2025-FY

Gross margin

15.0%+2.4% pts

Operating margin

-2.1%-4.2% pts

Net margin

-4.8%-6.1% pts

FCF margin

5.8%+4.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$67.55B$67.55B$62.45B$60.02B$75.64B
Net Income$-3.26B$-3.26B$-433.5M$441.3M$962.8M
EBITDA$93.0M$93.0M$1.10B$1.85B$2.62B
EPS-167.00-167.00-22.0023.0051.00
Gross Margin15.0%15.0%12.8%13.7%12.6%
Operating Margin-2.1%-2.1%0.3%0.0%2.1%
Net Margin-4.8%-4.8%-0.7%0.7%1.3%
Balance Sheet
Debt/Equity0.240.240.260.080.28
Current Ratio2.092.09———
Cash Flow
Free Cash Flow$3.95B$3.95B$-1.07B$2.60B$703.9M
Returns
ROE-8.1%-8.1%-1.0%1.0%2.4%
Valuation
P/E———208.2680.10
EV/EBITDA488.01488.0176.5150.6730.87
P/B1.041.041.772.081.89
Growth & Yield
Revenue Growth8.2%8.2%4.1%-20.7%—
EPS Growth-659.1%-659.1%-195.7%-54.9%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -41.1%

Total return

-41.1%

Start / end P/E

n/dx → n/dx

EPS bridge

-22.00 → -167.00

Residual

-41.1%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-41.1%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.